Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Singh-Franco D, McLaughlin-Middlekauff J, Elrod S, Harrington C.

Diabetes Obes Metab. 2012 Aug;14(8):694-708. doi: 10.1111/j.1463-1326.2012.01586.x. Epub 2012 Mar 20. Review.

PMID:
22340363
[PubMed - indexed for MEDLINE]
2.

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

Ismail-Beigi F, Craven TE, O'Connor PJ, Karl D, Calles-Escandon J, Hramiak I, Genuth S, Cushman WC, Gerstein HC, Probstfield JL, Katz L, Schubart U; ACCORD Study Group.

Kidney Int. 2012 Mar;81(6):586-94. doi: 10.1038/ki.2011.415. Epub 2011 Dec 14.

PMID:
22166848
[PubMed - indexed for MEDLINE]
3.

Clinical practice and implications of recent diabetes trials.

Webster MW.

Curr Opin Cardiol. 2011 Jul;26(4):288-93. doi: 10.1097/HCO.0b013e328347b139. Review.

PMID:
21577100
[PubMed - indexed for MEDLINE]
4.

[Management of type 2 diabetes in 2010. Insulins and injectable drugs: role of the general practitioner].

Renneboog B.

Rev Med Brux. 2010 Sep;31(4):377-84. French.

PMID:
21089418
[PubMed - indexed for MEDLINE]
5.

Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.

Reasner CA.

J Cardiovasc Pharmacol. 2008 Aug;52(2):136-44. doi: 10.1097/FJC.0b013e31817ffe5a. Review.

PMID:
18670366
[PubMed - indexed for MEDLINE]
6.

More choices than ever before: emerging therapies for type 2 diabetes.

Campbell RK, White JR Jr.

Diabetes Educ. 2008 May-Jun;34(3):518-34. doi: 10.1177/0145721708317870.

PMID:
18535325
[PubMed - indexed for MEDLINE]
7.

[Clinical characteristics of early-onset type 2 diabetes and risk factors associated with its chronic complications].

Zhang M, Li H, Zhang Z.

Zhonghua Yi Xue Za Zhi. 2006 Sep 26;86(36):2547-51. Chinese.

PMID:
17198563
[PubMed - indexed for MEDLINE]
8.

The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus.

Vasudevan AR, Burns A, Fonseca VA.

Treat Endocrinol. 2006;5(5):273-86.

PMID:
17002487
[PubMed - in process]
9.

Heart disease in diabetic patients.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):372-8. Review.

PMID:
16298258
[PubMed - indexed for MEDLINE]
10.

Diabetes mellitus and heart failure.

Sander GE, Giles TD.

Am Heart Hosp J. 2003 Fall;1(4):273-80. Review.

PMID:
15815121
[PubMed - indexed for MEDLINE]
11.

Slowing cardiovascular disease progression in African-American patients: diabetes management.

Gavin JR 3rd.

J Clin Hypertens (Greenwich). 2004 Apr;6(4 Suppl 1):26-33. Review.

PMID:
15073464
[PubMed - indexed for MEDLINE]
12.

Insulin resistant state in type 2 diabetes is related to advanced autonomic neuropathy.

Nakano S, Kitazawa M, Ito T, Hatakeyama H, Nishizawa M, Nakagawa A, Kigoshi T, Uchida K.

Clin Exp Hypertens. 2003 Apr;25(3):155-67.

PMID:
12716078
[PubMed - indexed for MEDLINE]
13.

Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.

Reaven GM.

Diabetes Obes Metab. 2002 Jan;4 Suppl 1:S13-8. Review.

PMID:
11843950
[PubMed - indexed for MEDLINE]
14.

Retinopathy in older type II diabetics. Association with glucose control.

Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC.

Diabetes. 1986 Jul;35(7):797-801.

PMID:
3721064
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk